These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12579708)

  • 1. [Cyclosporine A and thiotepa in prevention of postoperative recurrence of pterygium].
    Wu H; Chen G
    Yan Ke Xue Bao; 1999 Jun; 15(2):91-2. PubMed ID: 12579708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triethylene thiophosphoramide (thio-tepa) and pterygium.
    Liddy BS; Morgan JF
    Am J Ophthalmol; 1966 May; 61(5 Pt 1):888-90. PubMed ID: 16874990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of pterygia: should thiotepa be used?
    Olander K; Haik KG; Haik GM
    Ann Ophthalmol; 1978 Jul; 10(7):853-62. PubMed ID: 98089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pterygium treatment with triethylene thiophosphoramide.
    Chapman-Smith JS
    Aust N Z J Ophthalmol; 1992 May; 20(2):129-31. PubMed ID: 1389130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon Alpha-2b Eye Drops Prevent Recurrence of Pterygium After the Bare Sclera Technique: A Single-Center, Sequential, and Controlled Study.
    Yin M; Li H; Zhang Y; Dai H; Luo F; Pan Z
    Cornea; 2019 Oct; 38(10):1239-1244. PubMed ID: 31299663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thiotepa eyedrops for prevention of pterygium recurrence: 18 years of use].
    Tassy A; Ribe D
    J Fr Ophtalmol; 1999 Mar; 22(2):215-9. PubMed ID: 10327354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical cyclosporine A administration after pterygium surgery.
    Özülken K; Koç M; Ayar O; Hasiripi H
    Eur J Ophthalmol; 2012; 22 Suppl 7():S5-10. PubMed ID: 21725937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibition of pterygium recurrence by thio-tepa.
    Cassady JR
    Am J Ophthalmol; 1966 May; 61(5 Pt 1):886-8. PubMed ID: 16874989
    [No Abstract]   [Full Text] [Related]  

  • 9. Topical cyclosporine A in the prevention of pterygium recurrence.
    Yalcin Tok O; Burcu Nurozler A; Ergun G; Akbas Kocaoglu F; Duman S
    Ophthalmologica; 2008; 222(6):391-6. PubMed ID: 18765950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of pterygium recurrence in patients treated with thio-tepa.
    Joselson GA; Muller P
    Am J Ophthalmol; 1966 May; 61(5 Pt 1):891-2. PubMed ID: 16874991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bare sclera, scleral cautery and corticosteroid therapy of endemic pterygium in the Navajo Indian.
    Portney GL
    Am J Ophthalmol; 1969 May; 67(5):759-61. PubMed ID: 4976927
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adjuvant treatment with mitomycin eyedrops after pterygium excision: Ticino experience].
    Simona F; Anastasi-Forni C; Benedetti C; Failla FG; Rossi FM; Meyer U
    Klin Monbl Augenheilkd; 1994 May; 204(5):409-12. PubMed ID: 8051885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of pterygia with and without thiotepa.
    Colvin C
    Trans Ophthalmol Soc N Z; 1973; 25():67-9. PubMed ID: 4202569
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of single-drop mitomycin C regime with other mitomycin C regimes in pterygium surgery.
    Gupta VP; Saxena T
    Indian J Ophthalmol; 2003 Mar; 51(1):59-65. PubMed ID: 12701864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of 0.05% topical cyclosporine A versus 0.1% topical cyclosporine A on recurrence and clinical parameters following pterygium surgery.
    Güçlü ES; Metin T; Özer Ö; Bektaş FM
    Turk J Med Sci; 2024; 54(4):675-681. PubMed ID: 39295613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pterygium excision using 193-nm excimer laser smoothing and topical mitomycin C.
    Seiler T; Schnelle B; Wollensak J
    Ger J Ophthalmol; 1992; 1(6):429-31. PubMed ID: 1490143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of artificial tears in reducing the recurrence of pterygium after surgery: a prospective randomized controlled trial.
    Kampitak K; Leelawongtawun W; Leeamornsiri S; Suphachearaphan W
    Acta Ophthalmol; 2017 May; 95(3):e227-e229. PubMed ID: 27520087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative mitomycin-C versus postoperative topical mitomycin-C drops for the treatment of pterygium.
    Helal M; Messiha N; Amayem A; el-Maghraby A; Elsherif Z; Dabees M
    Ophthalmic Surg Lasers; 1996 Aug; 27(8):674-8. PubMed ID: 8858633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical cyclosporine A 0.05% before and after surgery to prevent pterygium recurrence.
    Meneghim RLFS; Satto LH; Natsuaki KL; Oliveira AC; Padovani CR; Viveiros MMH; Schellini SA
    Arq Bras Oftalmol; 2019 Jun; 82(5):372-376. PubMed ID: 31271569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thio-TEPA therapy to prevent postoperative pterygium occurrence and neovascularization.
    Kleis W; Picó G
    Am J Ophthalmol; 1973 Sep; 76(3):371-3. PubMed ID: 4199542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.